Compare Globus Medical Inc. Class A Common Stock (GMED) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Robinhood Markets, Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Robinhood Markets, Inc. trades at $99.03 (market cap $99.37B). The key difference: Robinhood Markets, Inc. is far larger — about 9.7× Globus Medical Inc. Class A Common Stock's market cap, and Robinhood Markets, Inc. is more actively traded (14,977,713 versus 1,108,124). Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Robinhood Markets, Inc. for 75 Days on average.
| GMED | HOOD | |
|---|---|---|
Market Cap | $10.25B | $99.37B |
Volume | 1,108,124 | 14,977,713 |
Sector | Health | Financials |
52-Week High | $96.82 | $147.08 |
52-Week Low | $58.33 | $65.16 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $9.76B | $105.91B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Robinhood (HOOD) trades at $101.08, down 7.45% in the last session, as investors digest mixed quarterly results. The stock shows neutral technical signals with support at $108 and resistance at $110. Fundamentally, the company demonstrates strong revenue growth from $3.0B in 2024 to $4.5B in 2025, with robust 42% net margins, though valuation multiples remain elevated with a P/E of 48.9. Recent announcements include plans for 24/7 stock trading and expanded crypto offerings.
Outlook remains positive with 77% analyst buy ratings and a $138.60 consensus price target implying 37% upside. Key opportunities include market share gains from new trading features, while risks involve high valuation sensitivity and regulatory scrutiny over leveraged crypto products. The Q3 2026 earnings report on October 27 will be critical for validating growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
